Clinical trial
Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH)…
NCT00033917 · Yale University, Other · Completed
Key facts
| NCT number | NCT00033917 |
|---|---|
| Title | Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial |
| Official title | Randomized Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial |
| Lead sponsor | Yale University, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Intraventricular Hemorrhage (IVH), Bleeding in the Brain, Prematurity, Very Low Birth Weight Infants |
| Intervention type | Drug |
| Interventions | indomethacin, placebo |
| Enrollment | 630 |
| Start date | Sep 1, 1989 |
| Primary completion | Mar 1, 2012 |
| Completion | Mar 1, 2012 |
| First posted | Apr 15, 2002 |
| Last update posted | Mar 28, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: